UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Struggling to find time for money-making? Here are ways to fit income opportunities into your busy schedule seamlessly.
27,638 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A voluntary recall of thousands of Waymo AVs grabbed headlines, but the bigger story is the decade ahead for autonomo...
U.S. equities extended gains as investors digested a leadership shift at the Federal Reserve and a cautious path for ...
A hedge fund's large bet on MercadoLibre has investors buzzing. This guide explains what the move might mean for MELI...
Dawn Kernicky, senior vice president of late-stage default at ServiceMac, champions a people-first approach to mortga...
AutoZone recently missed Wall Street estimates, sending shares lower before stabilizing. This guide breaks down what ...
A 50-person consultancy hired its first full-stack developer this January as Meta cuts thousands of jobs and AI resha...
As retirees turn 65, the six-month Medigap window is the only time insurers must offer standard rates. Missing it can...
Bitcoin faces first jobs-week as US labor data lands ahead of payrolls, guiding Fed bets and crypto volatility. Inves...
A high-profile CEO champions self-taught, AI-fluent leadership while leaning on a deep bench of scientists. The piece...
NVIDIA's Jensen Huang publicly praised Marvell at a major tech event, triggering a sharp stock move and fresh trillio...
A rapid 16% drop in AGQ sent shockwaves through leveraged-silver traders as the underlying metal faced a harsh repric...